Enantiospecific synthesis and receptor binding of novel dopamine receptor ligands employing natural 4-hydroxyproline as a practical and flexible building block

Tetrahedron Asymmetry

Volumn 14, Issue 20, 2003, Pages 3153-3172

  Heindl, Cornelia ^a   Hübner, Harald ^a   Gmeiner, Peter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; COPPER DERIVATIVE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR AFFECTING AGENT; LIGAND; N (1 BENZYL 4 HYDROXYPYRROLIDIN 2 YL) 5 CHLORO 2 METHOXY 4 METHYLAMINOBENZAMIDE; N [(1 BENZYL 4 BUTYLPYRROLIDIN 2 YL)METHYL] 5 CHLORO 2 METHOXY 4 METHYLAMIDOBENZAMIDE; N [(1 BENZYL 4 METHYLPYRROLIDIN 2 YL)METHYL] 5 CHLORO 2 METHOXY 4 METHYLAMINOBENZAMIDE; N [(2 BENZYL 4 METHYLPYRROLIDIN 2 YL)ETHYL] 5 CHLORO 2 METHOXY 4 METHYLAMINOBENZAMIDE; N [2 (1 BENZYL 4 BUTYLPYRROLIDIN 2 YL)ETHYL] 5 CHLORO 2 METHOXY 4 METHYLAMINOBENZAMIDE; N [2 (1 BENZYL 4 HYDROXYPYRROLIDIN 2 YL)ETHYL] 5 CHLORO 2 METHOXY 4 METHYLAMINOBENZAMIDE; PROLINE DERIVATIVE; PYRROLIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; CHIRALITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENANTIOSELECTIVITY; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 1642318711     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetasy.2003.08.020     Document Type: Article

References (49)

1. For earlier investigations, see: Iwanami S., Takashima M., Hirata Y., Hasegawa O., Usuda S. J. Med. Chem. 24:1981;1224. and references cited therein.
2. Preceeding paper and references cited therein.
3. Mishra R.K., Chiu S., Chiu P., Mishra C.P. Methods Find. Exp. Clin. Pharmacol. 5:1983;203.
4. Thomas C., Hübner H., Gmeiner P. Bioorg. Med. Chem. Lett. 9:1999;841.
5. Cossy J., Dumas C., Michel P., Gomez Pardo D. Tetrahedron Lett. 36:1995;549.
6. Watanabe K., Fukumura T., Sasaki S., Maeda M., Takehara S. Chem. Pharm. Bull. 39:1991;3211.
7. Gmeiner P., Kärtner A., Junge D. Tetrahedron Lett. 34:1993;4325.
8. Gmeiner P., Kärtner A. Synthesis. 1995;83.
9. Gmeiner P., Junge D., Kärtner A. J. Org. Chem. 59:1994;6766.
10. Gmeiner P. Arch. Pharm. (Weinheim Ger.). 324:1991;551.
11. Weber K., Gmeiner P. Synlett. 1998;885.
12. Cossy J., Dumas C., Gomez Pardo D. Eur. J. Org. Chem. 1999;1693.
13. Hammer C.F., Heller S.R., Craig J.H. Tetrahedron. 28:1972;239.
14. Hammer C.F., Weber J.D. Tetrahedron. 37:1981;2173.
15. Hammer C.F., McCarthy Ali M., Weber J.D. Tetrahedron. 29:1973;1767.
16. Brain E.G., Doyle F.P., Mehta M.D. J. Chem. Soc. 1961;633.
17. Moragues J., Prieto J., Spickett R.G.W., Vega A. J. Chem. Soc., Perkin Trans. 1. 1976;938.
18. Paul R., Tchelitcheff S. Bull. Soc. Chim. Fr. 1958;736.
19. Ikegami S., Uoji K., Akaboshi S. Tetrahedron. 30:1974;2077.
20. Thomas, C. Dissertation, Bonn, 1997.
21. Schumacher K.K., Jiang J., Joullie M.M. Tetrahedron: Asymmetry. 9:1998;47.
22. Jacobsen P., Labouta I.M., Schaumburg K., Falch E., Krogsgaard-Larsen P. J. Med. Chem. 25:1982;1157.
23. Koskinen A.M.P., Rapoport H. J. Org. Chem. 54:1989;1859.
24. Johnson C.R., Dutra G.A. J. Am. Chem. Soc. 95:1973;7777.
25. Johnson C.R., Dutra G.A. J. Am. Chem. Soc. 95:1973;7783.
26. Krause N., Gerold A. Angew. Chem., Int. Ed. Engl. 36:1997;186.
27. Hanessian S., Thavonekham B., DeHoff B. J. Org. Chem. 54:1989;5831.
28. Lipshutz B.H., Wilhelm R.S., Kozlowski J.A. Tetrahedron. 40:1984;5005.
29. Lipshutz B.H., Wilhelm R.S., Floyd D.M. J. Am. Chem. Soc. 103:1981;7672.
30. Lipshutz B.H. Synthesis. 1987;325.
31. Lipshutz B.H., Parker D., Kozlowski J.A., Miller R.D. J. Org. Chem. 48:1983;3334.
32. Nunomoto S., Kawakami Y., Yamashita Y. J. Org. Chem. 48:1983;1912.
33. Tamura M., Kochi J.K. J. Organomet. Chem. 1972;205.
34. Tamura M., Kochi J. Synthesis. 1971;303.
35. Erdik E. Tetrahedron. 40:1984;641.
36. Normant J.F. Pure Appl. Chem. 50:1978;709.
37. Hunter C., Jackson R.F.W., Rami H.K. J. Chem. Soc., Perkin Trans. 1. 2000;219.
38. Jackson R.F.W., Moore R.J., Dexter C.S., Elliott J., Mowbray C.E. J. Org. Chem. 63:1998;7875.
39. Knochel P., Singer R.D. Chem. Rev. 93:1993;2117.
40. Knochel P., Jones P. Organozinc Reagents, A Practical Approach. 1999;Oxford University Press.
41. Negishi E., Takahashi T., Baba S., Van Horn D.E., Okukado N. J. Am. Chem. Soc. 109:1987;2393.
42. Gibson T.W., Erman W.F. J. Am. Chem. Soc. 91:1969;4771.
43. Hayes G., Biden T.J., Selbie L.A., Shine J. J. Mol. Endocrinol. 6:1992;920.
44. Sokoloff P., Andrieux M., Besancon R., Pilon C., Martres M.-P., Giros B., Schwartz J.-C. Eur. J. Pharmacol. 225:1992;331.
45. Asghari V.S., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H.M. J. Neurochem. 65:1995;1157.
46. Hübner H., Haubmann C., Utz W., Gmeiner P. J. Med. Chem. 43:2000;756. and references cited therein.
47. Millan M.J. J. Pharmacol. Exp. Ther. 295:2000;853.
48. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265.
49. Cheng Y.C., Prusoff W.H. Biochem. Pharmacol. 22:1973;3099.